• Corpus ID: 32319715

Setting up the First Registry for Inflammatory Bowel Disease, Suspected to Primary Immunodeficiency Diseases in Iran

  title={Setting up the First Registry for Inflammatory Bowel Disease, Suspected to Primary Immunodeficiency Diseases in Iran},
  author={RoyaSherkat and SomayehNajafi and MajidYaran and Mohammad Hassan Emami and HoseinSaneian and Hamid Tavakoli and FereshtehKiani and Mohammad Mousazadeh and FaribaVakili and SoodabehRostami and NiooshaNekooie-Marnany},
Background: inflammatory bowel disease (IBD) has been considered a hyperinflammatory state due to disturbed interactions between the immune system and the commensal bacterial flora of the gut and suggesting IBD asa primary immunodeficiencies (PID). Therefore a registry launched about IBD, suspected to PID (IBDSPID) for the first time in Iran to raise awareness about this disease, to identify its risk factors, to early diagnosis and treatment. Materials and Methods: Among of 365 patients, 39… 

Tables from this paper


Epidemiology of Inflammatory Bowel Disease in Iran: A review of 803 cases
Although the true epidemiologic profile of IBD in Iran is still unknown, it is not as rare as previously thought and it seems as if gradual adoption of a western lifestyle may be associated with continuing rise in IBD.
Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A Review of 740 Patients in Fars Province, Southern Iran
An obvious increase in the number of IBD patients has been detected in the population of southern Iran during the past decades, and this alarming increase should be taken into consideration by both the health authorities and the researchers of the field in the authors' society.
Effects of family history on inflammatory bowel disease characteristics in Japanese patients
Disease characteristics of IBD vary in some aspects according to the presence or absence of a family history, whereas age was associated with levels of independence in daily life among UC patients.
Atypical Manifestation of LRBA Deficiency with Predominant IBD-like Phenotype
A patient with a novel missense mutation in LRBA who presented with IBD-like symptoms at early age is described, illustrating that LRBA deficiency should be considered in the differential diagnosis for IBD(-like) disease even in the absence of overt immunodeficiency.
Inflammatory bowel disease in children 5 years of age and younger
Failure to thrive, at the time of presentation, is indicative of a final diagnosis of CD or IC, not UC, and linear growth failure is a common finding in patients with early onset CD.
New pathophysiological insights and modern treatment of IBD
This review summarizes current epidemiology, pathogenesis and diagnostic strategies in IBD, provides insight in today’s differentiated clinical therapy and describes mechanisms of promising future medicinal approaches.
Bronchial Hyperreactivity and Allergic Status in Inflammatory Bowel Disease
Investigation of the prevalence of abnormal pulmonary function tests, BHR and the atopic status in patients with inflammatory bowel disease found allergic symptoms, respiratory symptoms, abnormal lung function tests and skin prick test positivity were more common among the IBD patients in comparison with the controls.
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study.
The emergence of IBD in Asia will result in the need for specific health care resources, and offers a unique opportunity to study etiologic factors in developing nations, says this large-scale population-based study.
Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988–2012)
The distribution of PIDs was different from that reported in Western countries, with a particularly high proportion of Combined Immunodeficiencies and phagocyte defects in number and/or function.
Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.
  • S. Agarwal, L. Mayer
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2013
Treatment of immunodeficient patients with concomitant gastrointestinal disease can be challenging, and therapy with immunomodulators often is required for severe disease.